» Authors » Marcel Kremser

Marcel Kremser

Explore the profile of Marcel Kremser including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 33
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Weiss N, Vierbaum L, Kremser M, Kaufmann-Stoeck A, Kappler S, Ballert S, et al.
Front Mol Biosci . 2024 Aug; 11:1401405. PMID: 39176390
Background: C-reactive protein (CRP) is an established serum biomarker for different pathologies such as tissue injury and inflammatory events. One rising area of interest is the incorporation of low concentrations...
2.
Kremser M, Weiss N, Kaufmann-Stoeck A, Vierbaum L, Schmitz A, Schellenberg I, et al.
Front Mol Biosci . 2024 Jul; 11:1401619. PMID: 38966130
Background: Tumor markers are established laboratory tools that help to diagnose, estimate prognosis, and monitor the course of cancer. For meaningful decision-making in patient care, it is essential that methods...
3.
Kremser M, Weiss N, Kaufmann-Stoeck A, Vierbaum L, Kappler S, Schellenberg I, et al.
Front Mol Biosci . 2024 Apr; 11:1373114. PMID: 38601324
Background: Quality control (QC), quality assurance, and standardization are crucial for modern diagnostic testing in the field of medical microbiology. The need for efficient QC to ensure accurate laboratory results,...
4.
Vierbaum L, Weiss N, Kaiser P, Kremser M, Wenzel F, Thevis M, et al.
Front Mol Biosci . 2024 Feb; 11:1345356. PMID: 38357630
As hormonal disorders are linked to several diseases, the accurate quantitation of steroid hormone levels in serum is crucial in order to provide patients with a reliable diagnosis. Mass spectrometry-based...
5.
Rohlfing A, Kremser M, Schaale D, Dicenta-Baunach V, Laspa Z, Fu X, et al.
Thromb Res . 2024 Jan; 234:63-74. PMID: 38171216
Background And Aims: Hemolysis is a known risk factor for thrombosis resulting in critical limb ischemia and microcirculatory disturbance and organ failure. Intravasal hemolysis may lead to life-threatening complications due...
6.
Fink A, Rohlfing A, Dicenta V, Schaale D, Kremser M, Laspa Z, et al.
Thromb Haemost . 2023 Apr; 123(7):679-691. PMID: 37037200
Introduction:  Hemolysis results in release of free hemoglobin and hemin liberation from erythrocytes. Hemin has been described to induce platelet activation and to trigger thrombosis. Methods:  We evaluated the effect...
7.
Rohlfing A, Kolb K, Sigle M, Ziegler M, Bild A, Munzer P, et al.
Nat Commun . 2022 Apr; 13(1):1823. PMID: 35383158
Platelet activation plays a critical role in thrombosis. Inhibition of platelet activation is a cornerstone in treatment of acute organ ischemia. Platelet ACKR3 surface expression is independently associated with all-cause...
8.
Nestele J, Rohlfing A, Dicenta V, Bild A, Eissler D, Emschermann F, et al.
Int J Mol Sci . 2022 Jan; 23(1). PMID: 35008437
Traditional antithrombotic agents commonly share a therapy-limiting side effect, as they increase the overall systemic bleeding risk. A novel approach for targeted antithrombotic therapy is nanoparticles. In other therapeutic fields,...
9.
Petersen-Uribe A, Kremser M, Rohlfing A, Castor T, Kolb K, Dicenta V, et al.
Int J Mol Sci . 2021 Oct; 22(20). PMID: 34681838
Platelets play a significant role in atherothrombosis. Proprotein convertase subtilisin/kexin type 9 (PCSK9) is critically involved in the regulation of LDL metabolism and interacts with platelet function. The effect of...